4-(4-(4-methoxyphenyl)phthalazin-1-ylamino)benzenesulfonamide

ID: ALA5208678

PubChem CID: 17129179

Max Phase: Preclinical

Molecular Formula: C21H18N4O3S

Molecular Weight: 406.47

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2nnc(Nc3ccc(S(N)(=O)=O)cc3)c3ccccc23)cc1

Standard InChI:  InChI=1S/C21H18N4O3S/c1-28-16-10-6-14(7-11-16)20-18-4-2-3-5-19(18)21(25-24-20)23-15-8-12-17(13-9-15)29(22,26)27/h2-13H,1H3,(H,23,25)(H2,22,26,27)

Standard InChI Key:  YZFSGMLQROGKMX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -0.7731    3.9173    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7731    3.0923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0566    2.6833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0566    1.8588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7742    1.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4877    1.8572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4877    2.6797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7742    0.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0576    0.2072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0576   -0.6136    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7691   -1.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7691   -1.8551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0546   -2.2675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0546   -3.0960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6617   -3.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3718   -3.0923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0863   -3.5049    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.4996   -2.7908    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9127   -3.5049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0863   -4.3298    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3718   -2.2671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6599   -1.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4867   -0.6161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1965   -1.0278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9127   -0.6198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9127    0.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1983    0.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4867    0.2088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4875    4.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  7  6  1  0
  2  7  2  0
  8  5  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  2  0
 17 20  1  0
 16 21  2  0
 21 22  1  0
 22 13  2  0
 23 11  1  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 28  8  1  0
 23 28  2  0
  1 29  1  0
M  END

Associated Targets(Human)

ENPP3 Tchem Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 406.47Molecular Weight (Monoisotopic): 406.1100AlogP: 3.70#Rotatable Bonds: 5
Polar Surface Area: 107.20Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.74CX Basic pKa: 3.07CX LogP: 3.28CX LogD: 3.28
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -1.33

References

1. Lee SY, Namasivayam V, Boshta NM, Perotti A, Mirza S, Bua S, Supuran CT, Müller CE..  (2021)  Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.,  12  (7.0): [PMID:34355184] [10.1039/D1MD00117E]
2. Ahmad, Haseen and 7 more authors.  2020-12-15  Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.  [PMID:32883636]

Source